← Back to Search

Behavioral Intervention

eSupport Health Weekly Group Sessions for PwMS for Multiple Sclerosis (CONNECT Trial)

N/A
Waitlist Available
Led By Victoria M Leavitt, Leavitt
Research Sponsored by eSupport Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, 20-40 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests an online support group for adults with MS, especially Black and Latinx individuals. The sessions are led by a therapist and aim to improve mental health through mutual respect and trust.

Eligible Conditions
  • Multiple Sclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, 20-40 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, 20-40 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence and completion
Secondary study objectives
Hospital Anxiety and Depression Scale (HADS)
Other study objectives
Functional Assessment in MS (FAMS)
Treatment adherence / healthcare utilization
UCLA Loneliness Scale Version 3

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: PwMS eSupport GroupsExperimental Treatment1 Intervention
12-weeks active treatment of eSupport Health's Weekly Group Sessions, a formal semi-structured program of psychoeducational support delivered in a small group format by licensed therapists who specialize in MS. The active treatment period will follow a 12-week waitlist period that will be used to enable a within-subject control design. Note that the very first group enrolled (N\~10) will not have a 12-week waitlist period but will instead enter directly into the 12-week treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eSupport Health Weekly Group Sessions for PwMS
2021
N/A
~60

Find a Location

Who is running the clinical trial?

eSupport HealthLead Sponsor
Victoria M Leavitt, LeavittPrincipal InvestigatoreSupport Health, PBC
~12 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top